Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment combined with swellable microneedles for plaque psoriasis
ChiCTR2500096255Phase 4Not yet recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Jan 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in plaque psoriasis (2 arms), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoint: Psoriasis Area and Severity Index (PASI). Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2500096255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096255.